Trevena
TRVN
$0.39
Share price
-4.40%
Change (1 day)
-39.85%
Change (1 year)
Categories
EPS for Trevena (TRVN)
EPS in 2023 (TTM): -$4.48
According to Trevena's latest financial reports the company's current EPS (TTM) is -$4.48. In 2022 the company made an earnings per share (EPS) of -$7.72 an increase over its 2021 EPS that were of -$7.75.
EPS history for Trevena from 2013 to 2023
Annual EPS
| Year | EPS | Change |
|---|---|---|
| 2023 (TTM) | -$4.48 | -41.97% |
| 2022 | -$7.72 | -0.39% |
| 2021 | -$7.75 | 29.17% |
| 2020 | -$6.00 | -11.11% |
| 2019 | -$6.75 | -37.21% |
| 2018 | -$10.75 | -64.46% |
| 2017 | -$30.25 | -38.27% |
| 2016 | -$49.00 | 70.43% |
| 2015 | -$28.75 | -44.17% |
| 2014 | -$51.50 | 39.42% |
| 2013 | -$36.94 |
EPS for similar companies or competitors
| Company | EPS | EPS differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $14.15 | -415.85% | 🇺🇸 USA |
 Merck MRK | $1.82 | -140.66% | 🇺🇸 USA |
 Cytokinetics
CYTK | -$5.69 | 27.01% | 🇺🇸 USA |
 AcelRx Pharmaceuticals
ACRX | -$3.09 | -31.03% | 🇺🇸 USA |
 Cara Therapeutics
CARA | -$2.06 | -54.02% | 🇺🇸 USA |